The Yin Yang of cancer related inflammation

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Smoldering, nonresolving inflammation is part of the tumor microenvironment (Balkwill and Mantovani 2001; Coussens and Werb 2002; Mantovani et al. 2008a). Inflammatory cells and mediators are present in the microenvironment of cancers epidemiologically related or unrelated to inflammatory or infectious conditions. Leukocyte infiltration and the presence of soluble mediators such as cytokines, and chemokines are key characteristics of CRI. Conditions predisposing to cancer (e.g., inflammatory bowel disease, IBD) or genetic events that cause neoplastic transformation orchestrate the construction of an inflammatory microenvironment. Indeed, alterations of oncogenes drive the production of inflammatory mediators. Thus, an intrinsic pathway of inflammation (driven in tumor cells), as well as an extrinsic pathway driven by chronic inflammatory conditions have been identified, both of which contribute to tumor progression (Mantovani et al.

Original languageEnglish
Title of host publicationImmunologic Signatures of Rejection
PublisherSpringer New York
Pages11-16
Number of pages6
ISBN (Print)9781441972194, 9781441972187
DOIs
Publication statusPublished - 2011

Fingerprint

Yin-Yang
Tumor Microenvironment
Inflammation
Neoplasms
Oncogenes
Inflammatory Bowel Diseases
Chemokines
Leukocytes
Cytokines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The Yin Yang of cancer related inflammation. / Mantovani, Alberto; Garlanda, Cecilia; Allavena, Paola; Sica, Antonio; Locati, Massimo.

Immunologic Signatures of Rejection. Springer New York, 2011. p. 11-16.

Research output: Chapter in Book/Report/Conference proceedingChapter

@inbook{c2aa84892ee44b3081304c0c896b81b5,
title = "The Yin Yang of cancer related inflammation",
abstract = "Smoldering, nonresolving inflammation is part of the tumor microenvironment (Balkwill and Mantovani 2001; Coussens and Werb 2002; Mantovani et al. 2008a). Inflammatory cells and mediators are present in the microenvironment of cancers epidemiologically related or unrelated to inflammatory or infectious conditions. Leukocyte infiltration and the presence of soluble mediators such as cytokines, and chemokines are key characteristics of CRI. Conditions predisposing to cancer (e.g., inflammatory bowel disease, IBD) or genetic events that cause neoplastic transformation orchestrate the construction of an inflammatory microenvironment. Indeed, alterations of oncogenes drive the production of inflammatory mediators. Thus, an intrinsic pathway of inflammation (driven in tumor cells), as well as an extrinsic pathway driven by chronic inflammatory conditions have been identified, both of which contribute to tumor progression (Mantovani et al.",
author = "Alberto Mantovani and Cecilia Garlanda and Paola Allavena and Antonio Sica and Massimo Locati",
year = "2011",
doi = "10.1007/978-1-4419-7219-4_2",
language = "English",
isbn = "9781441972194",
pages = "11--16",
booktitle = "Immunologic Signatures of Rejection",
publisher = "Springer New York",

}

TY - CHAP

T1 - The Yin Yang of cancer related inflammation

AU - Mantovani, Alberto

AU - Garlanda, Cecilia

AU - Allavena, Paola

AU - Sica, Antonio

AU - Locati, Massimo

PY - 2011

Y1 - 2011

N2 - Smoldering, nonresolving inflammation is part of the tumor microenvironment (Balkwill and Mantovani 2001; Coussens and Werb 2002; Mantovani et al. 2008a). Inflammatory cells and mediators are present in the microenvironment of cancers epidemiologically related or unrelated to inflammatory or infectious conditions. Leukocyte infiltration and the presence of soluble mediators such as cytokines, and chemokines are key characteristics of CRI. Conditions predisposing to cancer (e.g., inflammatory bowel disease, IBD) or genetic events that cause neoplastic transformation orchestrate the construction of an inflammatory microenvironment. Indeed, alterations of oncogenes drive the production of inflammatory mediators. Thus, an intrinsic pathway of inflammation (driven in tumor cells), as well as an extrinsic pathway driven by chronic inflammatory conditions have been identified, both of which contribute to tumor progression (Mantovani et al.

AB - Smoldering, nonresolving inflammation is part of the tumor microenvironment (Balkwill and Mantovani 2001; Coussens and Werb 2002; Mantovani et al. 2008a). Inflammatory cells and mediators are present in the microenvironment of cancers epidemiologically related or unrelated to inflammatory or infectious conditions. Leukocyte infiltration and the presence of soluble mediators such as cytokines, and chemokines are key characteristics of CRI. Conditions predisposing to cancer (e.g., inflammatory bowel disease, IBD) or genetic events that cause neoplastic transformation orchestrate the construction of an inflammatory microenvironment. Indeed, alterations of oncogenes drive the production of inflammatory mediators. Thus, an intrinsic pathway of inflammation (driven in tumor cells), as well as an extrinsic pathway driven by chronic inflammatory conditions have been identified, both of which contribute to tumor progression (Mantovani et al.

UR - http://www.scopus.com/inward/record.url?scp=80054097205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054097205&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-7219-4_2

DO - 10.1007/978-1-4419-7219-4_2

M3 - Chapter

AN - SCOPUS:80054097205

SN - 9781441972194

SN - 9781441972187

SP - 11

EP - 16

BT - Immunologic Signatures of Rejection

PB - Springer New York

ER -